Correction: Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
Oncogene
.
2024 Jun;43(25):1972.
doi: 10.1038/s41388-024-02999-1.
Authors
Bowen Sun
1
2
,
Seth Mason
2
,
Robert C Wilson
2
,
Starr E Hazard
3
,
Yubao Wang
4
5
,
Rong Fang
4
5
6
,
Qiwei Wang
4
5
,
Elizabeth S Yeh
7
,
Meixiang Yang
1
,
Thomas M Roberts
4
5
,
Jean J Zhao
4
5
,
Qi Wang
8
Affiliations
1
The First Affiliated Hospital, Biomedical Translational Research Institute and School of Pharmacy, Jinan University, Guangzhou, 510632, China.
2
Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, 29425, USA.
3
Computational Biology Resource Center, Medical University of South Carolina, Charleston, SC, 29425, USA.
4
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.
5
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02115, USA.
6
Department of Pathology, Zhejiang Provincial Key Laboratory of Pathophysiology, Ningbo University School of Medicine, Ningbo, 315211, China.
7
Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, 29425, USA.
8
Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, 29425, USA.
[email protected]
.
PMID:
38811847
PMCID:
PMC11178485
DOI:
10.1038/s41388-024-02999-1
No abstract available
Publication types
Published Erratum